
Tasigna Capsule 200 mg (Nilotinib hydrochloride monohydrate)
220.6mg
Hard capsule · Prescription medication
Korea Novartis Co., Ltd.
Nilotinib hydrochloride monohydrate is an anticancer agent used for the treatment of chronic myeloid leukemia.
MFDS ingredient code M249741
Nilotinib hydrochloride monohydrate belongs to the class of tyrosine kinase inhibitors and is used in the treatment of chronic myeloid leukemia. This ingredient blocks abnormal growth signals in cancer cells, inhibiting their proliferation.
Nilotinib hydrochloride monohydrate selectively inhibits a specific enzyme in cancer cells, BCR-ABL tyrosine kinase. When this enzyme is activated, cancer cells proliferate indiscriminately, and by blocking it, the growth of cancer cells is halted.
Approved uses differ by product. Check each product's information for its actual use.
Nilotinib hydrochloride monohydrate has higher selectivity and inhibitory power against the BCR-ABL enzyme compared to existing tyrosine kinase inhibitors, making it effective in treating resistant patients. Additionally, unlike other similar components, it demonstrates stronger activity against certain mutations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total

220.6mg
Hard capsule · Prescription medication
Korea Novartis Co., Ltd.

165.45mg
Hard capsule · Prescription medication
Novartis Korea Co., Ltd.

55.15mg
Hard capsule · Prescription medication
Korea Novartis Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.